We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFNX
2476
DELISTED
Pfenex Inc.
PFNX
| $1.4M | ﹤0.01% |
168,130
-28,127
| -14% | -$210K |
|
2477
World Acceptance Corp
WRLD
$873M
| $1.4M | ﹤0.01% |
21,422
-238
| -1% | -$14.9K |
|
|
BFX
2478
DELISTED
BowFlex Inc.
BFX
| $1.4M | ﹤0.01% |
+151,233
| New | +$917K |
|
2479
Cytosorbents Corp
CTSO
$22.6M
| $1.4M | ﹤0.01% |
141,290
+20,581
| +17% | +$189K |
|
2480
Rigel Pharmaceuticals
RIGL
$750M
| $1.4M | ﹤0.01% |
76,333
+16,059
| +27% | +$289K |
|
|
RAPT
2481
DELISTED
RAPT Therapeutics
RAPT
| $1.39M | ﹤0.01% |
+6,000
| New | +$928K |
|
|
AMRS
2482
DELISTED
Amyris Inc.
AMRS
| $1.39M | ﹤0.01% |
325,436
+34,423
| +12% | +$114K |
|
2483
ImmunityBio
IBRX
$8.1B
| $1.39M | ﹤0.01% |
+112,796
| New | +$637K |
|
2484
Nomad Foods
NOMD
$1.68B
| $1.38M | ﹤0.01% |
64,402
-11,969
| -16% | -$250K |
|
|
UBX
2485
DELISTED
Unity Biotechnology
UBX
| $1.38M | ﹤0.01% |
15,888
+4,993
| +46% | +$370K |
|
|
PENG
2486
Penguin Solutions Inc
PENG
$2.99B
| $1.38M | ﹤0.01% |
101,350
+1,744
| +2% | +$22.2K |
|
2487
Equity Bancshares
EQBK
$1.05B
| $1.37M | ﹤0.01% |
78,669
-14,316
| -15% | -$237K |
|
2488
MannKind Corp
MNKD
$1.32B
| $1.37M | ﹤0.01% |
781,996
-135,601
| -15% | -$189K |
|
2489
Haverty Furniture Companies
HVT
$454M
| $1.37M | ﹤0.01% |
85,488
-20,363
| -19% | -$297K |
|
2490
HF Foods Group
HFFG
$83.4M
| $1.36M | ﹤0.01% |
150,814
+94,830
| +169% | +$690K |
|
|
JCAP
2491
DELISTED
Jernigan Capital, Inc.
JCAP
| $1.36M | ﹤0.01% |
99,189
+19,559
| +25% | +$252K |
|
2492
FRP Holdings
FRPH
$421M
| $1.35M | ﹤0.01% |
66,612
+10,724
| +19% | +$222K |
|
2493
MasterCraft Boat Holdings
MCFT
$590M
| $1.35M | ﹤0.01% |
70,943
-7,915
| -10% | -$99.6K |
|
|
TBCH
2494
Turtle Beach Corp
TBCH
$277M
| $1.34M | ﹤0.01% |
+91,320
| New | +$942K |
|
|
CCRN
2495
DELISTED
Cross Country Healthcare
CCRN
| $1.34M | ﹤0.01% |
217,473
-134,679
| -38% | -$826K |
|
|
KALV
2496
DELISTED
KalVista Pharmaceuticals
KALV
| $1.34M | ﹤0.01% |
110,535
+53,863
| +95% | +$573K |
|
2497
Stoke Therapeutics
STOK
$2.11B
| $1.34M | ﹤0.01% |
56,148
-29,962
| -35% | -$711K |
|
|
STFC
2498
DELISTED
State Auto Financial Corp
STFC
| $1.33M | ﹤0.01% |
74,652
-8,367
| -10% | -$179K |
|
2499
First Mid Bancshares
FMBH
$1.36B
| $1.33M | ﹤0.01% |
50,782
+1,167
| +2% | +$29.2K |
|
2500
Arcutis Biotherapeutics
ARQT
$3.18B
| $1.33M | ﹤0.01% |
43,955
+5,059
| +13% | +$146K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.